Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 9 of 575 for:    CARBON DIOXIDE AND anesthesia

Rebreathing of Carbon Dioxide With a Device Used for Giving Inhalational Anaesthesia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01339013
Recruitment Status : Completed
First Posted : April 20, 2011
Results First Posted : September 11, 2014
Last Update Posted : September 25, 2014
Sponsor:
Information provided by (Responsible Party):
Region Skane

Study Type Interventional
Study Design Intervention Model: Single Group Assignment;   Masking: None (Open Label);   Primary Purpose: Basic Science
Condition Anesthetic Ventilatory Requirements
Intervention Device: Anesthetic Conserving Device (AnaConDa )
Enrollment 6
Recruitment Details September 2011 to January 2013, Medical Clinic
Pre-assignment Details All recruited patients participated uneventfully.
Arm/Group Title AnaConDa Replaces the Heat and Moisture Exchanger
Hide Arm/Group Description The conventional Heat and Moisture Exchanger is replaced by the AnaConDa which in turn is replaced by the conventional Heat and Moisture Exchanger.
Period Title: Overall Study
Started 6
Completed 6
Not Completed 0
Arm/Group Title All Study Participants
Hide Arm/Group Description Heat and Moisture Exchanger, then AnaConDa, finally Heat and Moisture Exchanger
Overall Number of Baseline Participants 6
Hide Baseline Analysis Population Description
A total of 6 patients participated. All 6 started with HME, then AnaConDa, finally HME
Age, Continuous  
Median (Full Range)
Unit of measure:  Years
Number Analyzed 6 participants
63
(58 to 75)
Age, Categorical  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 6 participants
<=18 years
0
   0.0%
Between 18 and 65 years
4
  66.7%
>=65 years
2
  33.3%
Sex: Female, Male  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 6 participants
Female
1
  16.7%
Male
5
  83.3%
Region of Enrollment  
Measure Type: Number
Unit of measure:  Participants
Sweden Number Analyzed 6 participants
6
1.Primary Outcome
Title Airway Dead Space With Devices for Heat and Moisture Exchange of Respiratory Gas.
Hide Description A conventional heat and moisture exchanger used in a respiratory circuit during anasthesia was exchanged by an AnaConDa. The AnaConDa causes re-breathing of carbon dioxide which clinically is equivalent to an increased airway dead space. The total airway dead space effect of the AnaConDa, i.e. volume of the device plus rebreathing from the charcoal filter was measured using the Single Breath Test for carbon dioxide, as was airway deadspace of the conventional Heat and Moisture Exchanger. Airway dead space differences between devices was calculated by subtraction of volumes thus achieved. Difference= Airway dead space AnaConDa - Airway dead space conventional Heat and Moisture Exchanger.
Time Frame 1 hour
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title AnaConDa
Hide Arm/Group Description:
Anesthetic Conserving Device (AnaConDa) has a charcoal filter.
Overall Number of Participants Analyzed 6
Median (95% Confidence Interval)
Unit of Measure: mL
136
(120 to 167)
Time Frame [Not Specified]
Adverse Event Reporting Description [Not Specified]
 
Arm/Group Title AnaConDa
Hide Arm/Group Description Anesthetic Conserving Device (AnaConDa or ACD) has a charcoal filter.
All-Cause Mortality
AnaConDa
Affected / at Risk (%)
Total   --/-- 
Show Serious Adverse Events Hide Serious Adverse Events
AnaConDa
Affected / at Risk (%)
Total   0/6 (0.00%) 
Show Other (Not Including Serious) Adverse Events Hide Other (Not Including Serious) Adverse Events
Frequency Threshold for Reporting Other Adverse Events 0%
AnaConDa
Affected / at Risk (%)
Total   0/6 (0.00%) 
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
Results Point of Contact
Layout table for Results Point of Contact information
Name/Title: Dr Louise Walther Sturesson
Organization: Region Skane, Lund University Hospital, Lund, Sweden
Phone: +46 46 171953
EMail: louise.waltersturesson@skane.se
Layout table for additonal information
Responsible Party: Region Skane
ClinicalTrials.gov Identifier: NCT01339013     History of Changes
Other Study ID Numbers: 20110322
First Submitted: April 13, 2011
First Posted: April 20, 2011
Results First Submitted: March 14, 2014
Results First Posted: September 11, 2014
Last Update Posted: September 25, 2014